Active substance
Results for the substance etelcalcetide
3 results
About this active substance
Etelcalcetide is a medication used to treat secondary hyperparathyroidism in patients with chronic kidney failure undergoing dialysis. It works by reducing the level of parathyroid hormone, helping to maintain the balance of calcium and phosphorus in the body.
Etelcalcetide is administered by intravenous injection, usually at the end of each dialysis session, according to the specialist doctor's instructions. The dose is adjusted based on blood test results and the patient's response to treatment.
Side effects may include low blood calcium levels (hypocalcemia), nausea, vomiting, muscle cramps, or, rarely, allergic reactions. Careful monitoring of blood tests is essential during treatment.
Etelcalcetide is an effective option for controlling hyperparathyroidism in patients with kidney failure, helping to prevent bone and cardiovascular complications associated with this condition.
Etelcalcetide is administered by intravenous injection, usually at the end of each dialysis session, according to the specialist doctor's instructions. The dose is adjusted based on blood test results and the patient's response to treatment.
Side effects may include low blood calcium levels (hypocalcemia), nausea, vomiting, muscle cramps, or, rarely, allergic reactions. Careful monitoring of blood tests is essential during treatment.
Etelcalcetide is an effective option for controlling hyperparathyroidism in patients with kidney failure, helping to prevent bone and cardiovascular complications associated with this condition.
-
-
PARSABIV 10mg solution for injection AMGEN ORIGINAL MEDICINE
-
PARSABIV 5mg solution for injection AMGEN ORIGINAL MEDICINE